IQSM — NYLI Candriam U.S. Mid Cap Equity ETF
Data updated: 2026-07-10
IQSM — NYLI Candriam U.S. Mid Cap Equity ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Mid Cap Blend / Core Equity · $315.04M AUM · 0.15% expense ratio · 26.1% 1-yr return. From SEC regulatory filings.
IQSM Fund Overview
IQSM — NYLI Candriam U.S. Mid Cap Equity ETF is a US ETF managed by New York Life Investments ETF Trust, categorised as United States Mid Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: New York Life Investments ETF Trust
- Category: United States Mid Cap Blend / Core Equity
- Assets under management: $315.04M
- 1-year return: 26.1%
- Ticker: IQSM
- SEC CIK: 0001415995
- SEC series ID: S000077598
- Share class ID: C000238086
IQSM Holdings
Top 10 holdings of NYLI Candriam U.S. Mid Cap Equity ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Technipfmc PLC | 1.31% |
| Fabrinet | 1.13% |
| Revolution Medicines, Inc. | 1.10% |
| Xpo, Inc. | 1.09% |
| Mastec, Inc. | 1.09% |
| United Therapeutics Corp. | 1.05% |
| Nvent Electric PLC | 0.99% |
| Albemarle Corp. | 0.99% |
| Twilio, Inc. | 0.88% |
| Ch Robinson Worldwide, Inc. | 0.87% |
IQSM Portfolio Allocation
Asset-class allocation of NYLI Candriam U.S. Mid Cap Equity ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.9% |
| Cash & Equivalents | 0.1% |
IQSM Performance
Total returns for IQSM (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 7.6% |
| 1 year | 26.1% |
| 3 years (annualised) | 12.9% |
IQSM Risk Information
Risk metrics for IQSM, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 10.8%
IQSM Costs and Fees
IQSM costs about $15 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.15%
- Gross expense ratio: 0.16%
- Portfolio turnover: 47%
- Brokerage commissions: 3.73 bps of average net assets (SEC N-CEN)
IQSM Cashflows
Over the 12 months to 2026-04, NYLI Candriam U.S. Mid Cap Equity ETF had net inflows of $68.21M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $16.17M |
| 2026-03 | $12.94M |
| 2026-02 | $45.10M |
| 2026-01 | $15.66M |
| 2025-12 | −$1.05M |
| 2025-11 | −$6.61M |
IQSM Debt Constituents
No individual debt constituents are reported in NYLI Candriam U.S. Mid Cap Equity ETF's latest SEC N-PORT filing.
IQSM Prospectus and SEC Filings
Official NYLI Candriam U.S. Mid Cap Equity ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Mid Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.